Key result
SCN5A Cys1384Phe variant reduces sodium current ~33% via dominant-negative suppression, linking to Brugada, SSS, and DCM.
Why the study?
Loss-of-function SCN5A variants are primarily associated with Brugada syndrome but can present with overlapping phenotypes, prompting investigation of a novel missense variant, Cys1384Phe.
Observational (n=15)
The novel SCN5A Cys1384Phe variant is a complete loss-of-function mutation with dominant-negative suppression that causes an overlapping phenotype of Brugada syndrome, sick sinus syndrome, and dilated cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for SCN5A overlap syndromes; leaves open causality and management pending larger studies.
BACKGROUND: Loss-of-function SCN5A variants are primarily associated with Brugada syndrome (BrS), but can also present with overlapping phenotypes. We investigated Cys1384Phe of SCN5A, a novel missense variant associated with BrS, sick sinus syndrome (SSS), and dilated cardiomyopathy (DCM). METHODS AND RESULTS: This study included a large 4-generation Japanese family consisting of 15 individuals (1 proband and 14 family members). Among them, the proband, a cousin, a second cousin and the second cousin's father were diagnosed with BrS. Two of these 4 BrS patients experienced VF events, while the other 2 remained asymptomatic. Another cousin was diagnosed with DCM, and 3 additional family members exhibited complete right bundle branch block and/or SSS. Comprehensive genetic analysis using a target panel sequencing identified a novel missense variant, Cys1384Phe in SCN5A, in the proband and affected family members; however, the phenotypes were different. Whole-cell patch-clamp experiments using HEK293 cells transfected wild-type or Cys1384Phe plasmid demonstrated a complete loss-of-function in the sodium current of the Cys1384Phe cells. Furthermore, the heterozygous expression of Cys1384Phe and wild-type (WT) channels showed a significant reduction of peak sodium current compared with the WT, suggesting a dominant-negative suppression, but no trafficking defect was observed. CONCLUSIONS: The novel Cys1384Phe variant in SCN5A is a complete loss-of-function mutation with dominant-negative suppression, and associated with overlapping phenotypes of BrS, SSS, and DCM.
No takes yet. Share an insight, caveat, or question.
Yamauchi et al. (2025) conducted an observational in Brugada syndrome, sick sinus syndrome, and dilated cardiomyopathy (n=15). SCN5A Cys1384Phe variant vs. Wild-type SCN5A was evaluated on Peak sodium current density (pA/pF at -40 mV) (p=<0.05). The novel SCN5A Cys1384Phe variant reduced peak sodium current by 32.9% through dominant-negative suppression and is associated with overlapping phenotypes of Brugada syndrome, sick sinus syndrome, and dilated cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: